• [1] LW,DJC.LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis.CELLULAR AND MOLECULAR LIFE SCIENCES,2023,81(1):
• [2] LW,DJC.MAVI1, an endoplasmic reticulum-localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion.SCIENCE ADVANCES,2022,9(35):
• [3] LW,DJC.CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting <i>ESR1</i> and MAVS.EMBO JOURNAL,2023,42(10):
• [4] LW,DJC.ER-localized JmjC domain- containing protein JMJD8 targets STING to promote immune evasion and tumor growth in breast cancer.DEVELOPMENTAL CELL,2023,58(9):760-+.
• [5] DJC.Estrogen-Induced LncRNA, LINC02568, Promotes Estrogen Receptor-Positive Breast Cancer Development and Drug Resistance Through Both <i>In</i> <i>Trans</i> and <i>In Cis</i> Mechanisms.Advanced Science,10(25):
• [6] LW,DJC.Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis.MOLECULAR CANCER,2022,21(1):
• [7] LW,YF,DJC.lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling.MOLECULAR THERAPY,2022,30(2):688-702.
• [8] XL,LW,DJC.BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma.MOLECULAR THERAPY,2021,29(10):3011-3026.
• [9] XL,LWX,DJC.EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo.CLINICAL & TRANSLATIONAL IMMUNOLOGY,2019,9(5):
• [10] YH,DJC.OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis.ADVANCED SCIENCE,8(15):-.